Is UiPath Stock a Buy or Sell After Its CEO Sells Shares Worth $2 Million?
Daniel Dines sold 135,000 shares over three days for a total value of ~$2,037,226.50 at a weighted average price of around $15.09 per share. The sale left Dines with 27,893,585 directly held shares and 9,615,297 indirectly held shares.
UiPath (PATH) Stock Drops Despite Market Gains: Important Facts to Note
In the most recent trading session, UiPath (PATH) closed at $14.36, indicating a -3.69% shift from the previous trading day.
PATH and APP: Two AI Stocks Worth Buying, But One Stands Stronger
UiPath's push into agentic AI, steady recurring revenue and lower valuation set it apart in a head-to-head with AppLovin's ad-tech momentum.
UiPath's Platform-Led Operating Leverage in the Age of Agentic AI
PATH is shifting automation to agentic AI, turning orchestration into operating leverage that deepens adoption, boosts margins and anchors workflows.
Is Trending Stock UiPath, Inc. (PATH) a Buy Now?
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
UiPath (PATH) Stock Drops Despite Market Gains: Important Facts to Note
UiPath (PATH) reached $14.2 at the closing of the latest trading day, reflecting a -1.18% change compared to its last close.
UiPath (PATH) Stock Sinks As Market Gains: Here's Why
UiPath (PATH) closed at $14.79 in the latest trading session, marking a -3.77% move from the prior day.
Why UiPath Is Poised To Outperform In The Age Of AI And Automation
UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. PATH's revenue growth re-accelerated to 15.9% in Q3 FY26, with raised full-year guidance and a clear path to first-time GAAP profitability in FY26. The unified RPA and agentic AI platform, including Maestro orchestration, expands automation scope and revenue potential, though direct agentic AI monetization remains nascent.
UiPath Inc. (PATH) Presents at 28th Annual Needham Growth Conference Transcript
UiPath Inc. (PATH) Presents at 28th Annual Needham Growth Conference Transcript
UiPath (PATH) is a Great Momentum Stock: Should You Buy?
Does UiPath (PATH) have what it takes to be a top stock pick for momentum investors? Let's find out.
UiPath is Regaining Market Confidence: What Should Investors Do Next?
PATH's rebound signals rising confidence as improving fundamentals, attractive valuation and AI automation progress lift the long-term outlook.
UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
